Trade Names: | |
Synonyms: | |
Status: | Approved (2016) |
Entry Type: | Antibody |
Molecule Category: | UNKNOWN |
ATC: | L01XC32 |
UNII: | 52CMI0WC3Y |
Action | Mechanism of Action | Reference |
---|---|---|
INHIBITOR | Programmed cell death 1 ligand 1 inhibitor | FDA |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Neoplasms | 4 | D009369 | ClinicalTrials |
Breast Neoplasms | 4 | D001943 | ClinicalTrials |
Breast Neoplasms | 4 | D001943 | ClinicalTrials |
Breast Neoplasms | 4 | D001943 | ClinicalTrials |
Lung Neoplasms | 4 | D008175 | ClinicalTrials |
Peritoneal Neoplasms | 3 | D010534 | ClinicalTrials |
Prostatic Neoplasms | 3 | D011471 | ClinicalTrials |
Small Cell Lung Carcinoma | 3 | D055752 | ClinicalTrials |
Melanoma | 3 | D008545 | ClinicalTrials |
Mesothelioma | 3 | D008654 | ClinicalTrials |
Urinary Bladder Neoplasms | 3 | D001749 | ClinicalTrials |
Uterine Cervical Neoplasms | 3 | D002583 | ClinicalTrials |
Fallopian Tube Neoplasms | 3 | D005185 | ClinicalTrials |
Ovarian Neoplasms | 3 | D010051 | ClinicalTrials |
Uterine Cervical Neoplasms | 3 | D002583 | ClinicalTrials |
Esophageal Neoplasms | 3 | D004938 | ClinicalTrials |
Ovarian Neoplasms | 3 | D010051 | ClinicalTrials |
Esophageal Neoplasms | 3 | D004938 | ClinicalTrials |
Esophageal Neoplasms | 3 | D004938 | ClinicalTrials |
Urogenital Neoplasms | 3 | D014565 | ClinicalTrials |
Triple Negative Breast Neoplasms | 3 | D064726 | ClinicalTrials |
Endometrial Neoplasms | 3 | D016889 | ClinicalTrials |
Carcinoma, Hepatocellular | 3 | D006528 | ClinicalTrials |
Mesothelioma | 3 | D008654 | ClinicalTrials |
Ovarian Neoplasms | 3 | D010051 | ClinicalTrials |
Carcinoma, Squamous Cell | 3 | D002294 | ClinicalTrials |
Colorectal Neoplasms | 3 | D015179 | ClinicalTrials |
Melanoma | 3 | D008545 | ClinicalTrials |
Carcinoma, Non-Small-Cell Lung | 3 | D002289 | ClinicalTrials |
Melanoma | 3 | D008545 | ClinicalTrials |
Prostatic Neoplasms | 3 | D011471 | ClinicalTrials |
Carcinoma, Renal Cell | 3 | D002292 | ClinicalTrials |
Urinary Bladder Neoplasms | 3 | D001749 | ClinicalTrials |
Carcinoma | 2 | D002277 | ClinicalTrials |
Leukemia, Lymphocytic, Chronic, B-Cell | 2 | D015451 | ClinicalTrials |
Lymphoma, Follicular | 2 | D008224 | ClinicalTrials |
Hodgkin Disease | 2 | D006689 | ClinicalTrials |
Lymphoma, Large B-Cell, Diffuse | 2 | D016403 | ClinicalTrials |
Stomach Neoplasms | 2 | D013274 | ClinicalTrials |
Glioblastoma | 2 | D005909 | ClinicalTrials |
Lymphoma | 2 | D008223 | ClinicalTrials |
Head and Neck Neoplasms | 2 | D006258 | ClinicalTrials |
Sarcoma, Alveolar Soft Part | 2 | D018234 | ClinicalTrials |
Rectal Neoplasms | 2 | D012004 | ClinicalTrials |
Sezary Syndrome | 2 | D012751 | ClinicalTrials |
Mycosis Fungoides | 2 | D009182 | ClinicalTrials |
Sarcoma | 2 | D012509 | ClinicalTrials |
Carcinoma, Pancreatic Ductal | 2 | D021441 | ClinicalTrials |
Pancreatic Neoplasms | 2 | D010190 | ClinicalTrials |
Head and Neck Neoplasms | 2 | D006258 | ClinicalTrials |
Cholangiocarcinoma | 2 | D018281 | ClinicalTrials |
Neoplasm Metastasis | 2 | D009362 | ClinicalTrials |
Retroviridae Infections | 2 | D012192 | ClinicalTrials |
Anus Neoplasms | 2 | D001005 | ClinicalTrials |
Kidney Neoplasms | 2 | D007680 | ClinicalTrials |
Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
Lymphoma, Follicular | 2 | D008224 | ClinicalTrials |
Biliary Tract Neoplasms | 2 | D001661 | ClinicalTrials |
Thyroid Neoplasms | 2 | D013964 | ClinicalTrials |
Cholangiocarcinoma | 2 | D018281 | ClinicalTrials |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | D015464 | ClinicalTrials |
Multiple Myeloma | 1 | D009101 | ClinicalTrials |
Liver Neoplasms | 1 | D008113 | ClinicalTrials |
Myelodysplastic Syndromes | 1 | D009190 | ClinicalTrials |
Glioma | 1 | D005910 | ClinicalTrials |
Leukemia, Myeloid, Acute | 1 | D015470 | ClinicalTrials |
Gliosarcoma | 1 | D018316 | ClinicalTrials |
Lymphoma, Non-Hodgkin | 1 | D008228 | ClinicalTrials |
Skin Neoplasms | 1 | D012878 | ClinicalTrials |
Hematologic Neoplasms | 1 | D019337 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 1380723-44-3 |
ChEMBL | CHEMBL3707227 |
FDA SRS | 52CMI0WC3Y |
Guide to Pharmacology | 7990 |